{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Alpine Immune Sciences, Inc."},"Symbol":{"label":"Symbol","value":"ALPN"},"Address":{"label":"Address","value":"188 EAST BLAINE STREET SUITE 200, SEATTLE, Washington, 98102, United States"},"Phone":{"label":"Phone","value":"+1 206 788-4545"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Alpine Immune Sciences Inc is a clinical-stage immunotherapy company. The company is focused on developing innovative treatments for autoimmune and inflammatory diseases. To improve the lives of patients, the group aims to create multifunctional immunotherapies through unique protein engineering technologies. Alpine has formed strategic collaborations with&nbsp;global biopharmaceutical companies and has a wide range of clinical and preclinical candidates in development. Its product pipeline includes ALPN-303, as well as acazicolcept (ALPN-101)."},"CompanyUrl":{"label":"Company Url","value":"https://www.alpineimmunesciences.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Mitchell H. Gold","title":"Executive Chairman &amp; Chief Executive Officer"},{"name":"Pamela Holland","title":"Senior Vice President-Research"},{"name":"Stanford L. Peng","title":"President &amp; Head-Research &amp; Development"},{"name":"Wayne R. Gombotz","title":"Chief Technology Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}